RHHVF - Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M | Benzinga
Friday, LumiraDx Limited (NASDAQ: LMDX) appointed joint administrators for two subsidiaries. The administrators signed a definitive agreement to sell certain companies of LumiraDx related to LumiraDx's point-of-care technology to Roche Holdings AG (OTC: RHHBY).
Separately, LumiraDx appointed Andrew Johnson, Lisa Rickelton, and Lindsay Hallam of FTI Consulting as joint administrators of two subsidiaries, LumiraDx Group Limited ...